Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug

Annachiara Mitrugno, Joanna L. Sylman, Rachel A. Rigg, Samuel Tassi Yunga, Joseph J. Shatzel, Craig D. Williams, Owen McCarty

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Cancer metastasis is a dynamic process during which cancer cells separate from a primary tumor, migrate through the vessel wall into the bloodstream, and extravasate at distant sites to form secondary colonies. During this process, circulating tumor cells are subjected to shear stress forces from blood flow, and in contact with plasma proteins and blood cells of the immune and hemostatic system, including platelets. Many studies have shown an association between high platelet count and cancer metastasis, suggesting that platelets may play an occult role in tumorigenesis. This mini-review summarizes recent and emerging discoveries of mechanisms by which cancer cells activate platelets and the role of activated platelets in promoting tumor growth and metastasis. Moreover, the review discusses how aspirin has the potential for being clinically used as an adjuvant in cancer therapy.

Original languageEnglish (US)
Pages (from-to)773-778
Number of pages6
JournalPlatelets
Volume29
Issue number8
DOIs
StatePublished - Nov 17 2018

Fingerprint

Aspirin
Blood Platelets
Pharmaceutical Preparations
Neoplasms
Neoplasm Metastasis
Circulating Neoplastic Cells
Hemostatics
Plasma Cells
Platelet Count
Blood Proteins
Immune System
Blood Cells
Carcinogenesis
Growth

Keywords

  • Aspirin
  • Cancer
  • Platelets

ASJC Scopus subject areas

  • Hematology

Cite this

Mitrugno, A., Sylman, J. L., Rigg, R. A., Tassi Yunga, S., Shatzel, J. J., Williams, C. D., & McCarty, O. (2018). Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug. Platelets, 29(8), 773-778. https://doi.org/10.1080/09537104.2017.1416076

Carpe low-dose aspirin : the new anti-cancer face of an old anti-platelet drug. / Mitrugno, Annachiara; Sylman, Joanna L.; Rigg, Rachel A.; Tassi Yunga, Samuel; Shatzel, Joseph J.; Williams, Craig D.; McCarty, Owen.

In: Platelets, Vol. 29, No. 8, 17.11.2018, p. 773-778.

Research output: Contribution to journalReview article

Mitrugno, A, Sylman, JL, Rigg, RA, Tassi Yunga, S, Shatzel, JJ, Williams, CD & McCarty, O 2018, 'Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug', Platelets, vol. 29, no. 8, pp. 773-778. https://doi.org/10.1080/09537104.2017.1416076
Mitrugno A, Sylman JL, Rigg RA, Tassi Yunga S, Shatzel JJ, Williams CD et al. Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug. Platelets. 2018 Nov 17;29(8):773-778. https://doi.org/10.1080/09537104.2017.1416076
Mitrugno, Annachiara ; Sylman, Joanna L. ; Rigg, Rachel A. ; Tassi Yunga, Samuel ; Shatzel, Joseph J. ; Williams, Craig D. ; McCarty, Owen. / Carpe low-dose aspirin : the new anti-cancer face of an old anti-platelet drug. In: Platelets. 2018 ; Vol. 29, No. 8. pp. 773-778.
@article{66794fd02e4342c1b82dcdad38840f79,
title = "Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug",
abstract = "Cancer metastasis is a dynamic process during which cancer cells separate from a primary tumor, migrate through the vessel wall into the bloodstream, and extravasate at distant sites to form secondary colonies. During this process, circulating tumor cells are subjected to shear stress forces from blood flow, and in contact with plasma proteins and blood cells of the immune and hemostatic system, including platelets. Many studies have shown an association between high platelet count and cancer metastasis, suggesting that platelets may play an occult role in tumorigenesis. This mini-review summarizes recent and emerging discoveries of mechanisms by which cancer cells activate platelets and the role of activated platelets in promoting tumor growth and metastasis. Moreover, the review discusses how aspirin has the potential for being clinically used as an adjuvant in cancer therapy.",
keywords = "Aspirin, Cancer, Platelets",
author = "Annachiara Mitrugno and Sylman, {Joanna L.} and Rigg, {Rachel A.} and {Tassi Yunga}, Samuel and Shatzel, {Joseph J.} and Williams, {Craig D.} and Owen McCarty",
year = "2018",
month = "11",
day = "17",
doi = "10.1080/09537104.2017.1416076",
language = "English (US)",
volume = "29",
pages = "773--778",
journal = "Platelets",
issn = "0953-7104",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Carpe low-dose aspirin

T2 - the new anti-cancer face of an old anti-platelet drug

AU - Mitrugno, Annachiara

AU - Sylman, Joanna L.

AU - Rigg, Rachel A.

AU - Tassi Yunga, Samuel

AU - Shatzel, Joseph J.

AU - Williams, Craig D.

AU - McCarty, Owen

PY - 2018/11/17

Y1 - 2018/11/17

N2 - Cancer metastasis is a dynamic process during which cancer cells separate from a primary tumor, migrate through the vessel wall into the bloodstream, and extravasate at distant sites to form secondary colonies. During this process, circulating tumor cells are subjected to shear stress forces from blood flow, and in contact with plasma proteins and blood cells of the immune and hemostatic system, including platelets. Many studies have shown an association between high platelet count and cancer metastasis, suggesting that platelets may play an occult role in tumorigenesis. This mini-review summarizes recent and emerging discoveries of mechanisms by which cancer cells activate platelets and the role of activated platelets in promoting tumor growth and metastasis. Moreover, the review discusses how aspirin has the potential for being clinically used as an adjuvant in cancer therapy.

AB - Cancer metastasis is a dynamic process during which cancer cells separate from a primary tumor, migrate through the vessel wall into the bloodstream, and extravasate at distant sites to form secondary colonies. During this process, circulating tumor cells are subjected to shear stress forces from blood flow, and in contact with plasma proteins and blood cells of the immune and hemostatic system, including platelets. Many studies have shown an association between high platelet count and cancer metastasis, suggesting that platelets may play an occult role in tumorigenesis. This mini-review summarizes recent and emerging discoveries of mechanisms by which cancer cells activate platelets and the role of activated platelets in promoting tumor growth and metastasis. Moreover, the review discusses how aspirin has the potential for being clinically used as an adjuvant in cancer therapy.

KW - Aspirin

KW - Cancer

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=85058220002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058220002&partnerID=8YFLogxK

U2 - 10.1080/09537104.2017.1416076

DO - 10.1080/09537104.2017.1416076

M3 - Review article

C2 - 29265902

AN - SCOPUS:85058220002

VL - 29

SP - 773

EP - 778

JO - Platelets

JF - Platelets

SN - 0953-7104

IS - 8

ER -